pyruvate kinase inhibitor (Indel)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namepyruvate kinase inhibitor (Indel)
Drug Alias Nameanti-MRSA program (Indel)IND-2257IND-2255IND-2267
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics
Mechanisms of ActionPyruvate kinase inhibitors
TargetsPyruvate kinase
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIndel Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIndel Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsStaphylococcal Infections

Other Information

ATC CodeN/A
Related LinksN/A